XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 19, 2016
Jun. 14, 2015
Cash flows from operating activities:    
Net income $ 94,712 $ 92,198
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 16,756 15,028
Loss (gain) on sale/disposal of assets 247 (272)
Amortization of debt issuance costs 3,133 2,550
Provision (benefit) for deferred income taxes 1,775 (1,964)
Non-cash compensation expense 8,617 7,776
Tax impact from equity-based compensation (34,852) (7,556)
Other 16 (725)
Changes in operating assets and liabilities (20,951) (3,441)
Net cash provided by operating activities 69,453 103,594
Cash flows from investing activities:    
Capital expenditures (25,045) (20,238)
Proceeds from sale of assets 2,765 8,785
Changes in restricted cash 73,505 24,137
Other (904) 1,449
Net cash provided by investing activities 50,321 14,133
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 10,000  
Repayments of long-term debt and capital lease obligations (39,878) (141)
Proceeds from exercise of stock options 10,848 2,067
Tax impact from equity-based compensation 34,852 7,556
Purchases of common stock (224,139) (97,634)
Tax payments for restricted stock upon vesting (3,036) (3,737)
Payments of common stock dividends and equivalents (19,099) (31,039)
Net cash used in financing activities (230,452) (122,928)
Effect of exchange rate changes on cash and cash equivalents (466) 237
Change in cash and cash equivalents (111,144) (4,964)
Cash and cash equivalents, at beginning of period 133,449 [1] 30,855
Cash and cash equivalents, at end of period $ 22,305 $ 25,891
[1] The balance sheet at January 3, 2016 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.